Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  tretinoin
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Tretinoin and Arsenic Trioxide in Treating Patients with Untreated Acute Promyelocytic Leukemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 12 to 21
Trial IDs: AAML1331, NCI-2014-02266, PAAML1331_A01PAMDREVW0, NCT02339740
Tretinoin and Arsenic Trioxide in Treating Patients with Newly Diagnosed Acute Promyelocytic Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 11-040, NCI-2011-02334, NCT01404949
Tretinoin and Arsenic Trioxide with or without Gemtuzumab Ozogamicin in Treating Patients with Previously Untreated Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Age: 10 and over
Trial IDs: 2010-0981, NCI-2011-02767, NCT01409161
Dasatinib and Tretinoin in Treating Patients With Acute Myeloid Leukemia
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-160, NCI-2011-02494, NCT00892190
Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 3912, NCI-2013-00600, NCT01820624
Start Over